Literature DB >> 9034211

Quantitative analysis of plasma acylcarnitines using gas chromatography chemical ionization mass fragmentography.

C G Costa1, E A Struys, A Bootsma, H J ten Brink, L Dorland, I Tavares de Almeida, M Duran, C Jakobs.   

Abstract

A stable isotope dilution gas chromatography chemical ionization mass spectrometry (GC-CI-MS) method was developed for the quantitative profiling of plasma acylcarnitines. The clean-up procedure was comprised of a solid-phase cation exchange extraction using PRS-columns from which the acylcarnitines were eluted with a barium chloride solution. Isolated acylcarnitines were transformed into acyloxylactones and analyzed by positive GC-CI-MS using isobutane as reactant gas. The selected monitoring of a common ion at m/z [85]+ and the protonated molecular ion enabled a selective and sensitive detection of all C2-C18 acylcarnitines. An accurate quantitation was achieved by the use of stable isotope-labeled internal standards (C2-C18) and acylcarnitines could be analyzed in the sub-nanomolar range. Control values for C2-C18 acylcarnitines in plasma were established. Concentrations ranged from 0.02 micromol/L for C14-acylcarnitine to 4.90 micromol/L for C2-acylcarnitine. The diagnostic suitability of the method was demonstrated for patients with medium-chain acyl-CoA dehydrogenase deficiency and very long-chain acyl-CoA dehydrogenase deficiency.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9034211

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  12 in total

1.  Differential mobility spectrometry (DMS) reveals the elevation of urinary acetylcarnitine in non-human primates (NHPs) exposed to radiation.

Authors:  Nicholas B Vera; Zhidan Chen; Evan Pannkuk; Evagelia C Laiakis; Albert J Fornace; Derek M Erion; Stephen L Coy; Jeffrey A Pfefferkorn; Paul Vouros
Journal:  J Mass Spectrom       Date:  2018-07       Impact factor: 1.982

2.  Quantitative measurement of plasma 3-hydroxyisovaleryl carnitine by LC-MS/MS as a novel biomarker of biotin status in humans.

Authors:  Thomas D Horvath; Shawna L Stratton; Anna Bogusiewicz; Lindsay Pack; Jeffery Moran; Donald M Mock
Journal:  Anal Chem       Date:  2010-05-15       Impact factor: 6.986

3.  Plasma concentration of 3-hydroxyisovaleryl carnitine is an early and sensitive indicator of marginal biotin deficiency in humans.

Authors:  Shawna L Stratton; Thomas D Horvath; Anna Bogusiewicz; Nell I Matthews; Cindy L Henrich; Horace J Spencer; Jeffery H Moran; Donald M Mock
Journal:  Am J Clin Nutr       Date:  2010-10-13       Impact factor: 7.045

4.  Adolescent myopathic presentation in two sisters with very long-chain acyl-CoA dehydrogenase deficiency.

Authors:  B Merinero; S I Pascual Pascual; C Pérez-Cerdá; J Gangoiti; M Castro; M J Garcia; I Pascual Castroviejo; C Vianey-Saban; B Andresen; N Gregersen; M Ugarte
Journal:  J Inherit Metab Dis       Date:  1999-10       Impact factor: 4.982

5.  The effect of fasting, long-chain triglyceride load and carnitine load on plasma long-chain acylcarnitine levels in mitochondrial very long-chain acyl-CoA dehydrogenase deficiency.

Authors:  C G Costa; L Dorland; I T de Almeida; C Jakobs; M Duran; B T Poll-The
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

6.  Clear correlation of genotype with disease phenotype in very-long-chain acyl-CoA dehydrogenase deficiency.

Authors:  B S Andresen; S Olpin; B J Poorthuis; H R Scholte; C Vianey-Saban; R Wanders; L Ijlst; A Morris; M Pourfarzam; K Bartlett; E R Baumgartner; J B deKlerk; L D Schroeder; T J Corydon; H Lund; V Winter; P Bross; L Bolund; N Gregersen
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

7.  Quantitative measurement of urinary excretion of 3-hydroxyisovaleryl carnitine by LC-MS/MS as an indicator of biotin status in humans.

Authors:  Thomas D Horvath; Shawna L Stratton; Anna Bogusiewicz; Suzanne N Owen; Donald M Mock; Jeffery H Moran
Journal:  Anal Chem       Date:  2010-10-28       Impact factor: 6.986

8.  Neonatal screening for medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in The Netherlands: the importance of enzyme analysis to ascertain true MCAD deficiency.

Authors:  T G J Derks; T S Boer; A van Assen; T Bos; J Ruiter; H R Waterham; K E Niezen-Koning; R J A Wanders; J M M Rondeel; J G Loeber; L P Ten Kate; G P A Smit; D-J Reijngoud
Journal:  J Inherit Metab Dis       Date:  2008-01-14       Impact factor: 4.982

9.  Cell Culture Medium Formulation and Its Implications in Cancer Metabolism.

Authors:  Tobias Ackermann; Saverio Tardito
Journal:  Trends Cancer       Date:  2019-05-29

10.  Laboratory analysis of acylcarnitines, 2020 update: a technical standard of the American College of Medical Genetics and Genomics (ACMG).

Authors:  Marcus J Miller; Kristina Cusmano-Ozog; Devin Oglesbee; Sarah Young
Journal:  Genet Med       Date:  2020-10-19       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.